アジア太平洋地域の抗体発見市場予測 - 2030 年まで - 地域分析 - 抗体タイプ (モノクローナル抗体、ポリクローナル抗体、その他)、性質 (ヒトおよびヒト化、キメラ、マウス)、サービス (ファージディスプレイ、ハイブリドーマ、トランスジェニック動物、単一細胞、酵母ディスプレイ)、エンドユーザー (製薬およびバイオテクノロジー企業、研究機関、その他)
発展途上地域でのバイオテクノロジー産業の急増により、アジア太平洋地域の抗体発見市場が拡大
抗体は抗原を識別する際の優れた精度により、科学者や臨床医にとって非常に貴重なツールとなっています。現代のバイオテクノロジーでは、基礎研究から革新的な医療評価まで、さまざまなプロセスで抗体が必要です。治療用抗体の開発により、さまざまな疾患の治療に新たな道が開かれ、これらの粒子の変革能力が実証されています。抗体は、疾患の特定に正確で信頼性の高いアプローチを提供するため、抗体ベースの診断においても非常に重要です。政府からのサポートの拡大、官民パートナーシップの拡大、疾患プロファイルの継続的な変化、資金調達活動の増加により、アジア太平洋などの地域でバイオテクノロジー産業のパフォーマンスが幅広く向上しています。
経済協力開発機構（OECD）によると、2019年の時点で中国は研究開発費の面で先頭に立っていました。多額の投資により、ヘルスケア分野での先進技術の採用が促進されています。アジアなどの地域の国々の政府は、バイオテクノロジー企業の能力拡大と強化を奨励するために、税制優遇措置、より安価な土地、直接投資を提供しています。したがって、台湾、マレーシア、インド、中国、シンガポール、日本などの国は、バイオテクノロジー産業にとって最も有利な目的地の1つです。さらに、これらのアジア諸国は、診断および治療アプリケーションでのゲノミクス、プロテオミクス、バイオマーカーの進歩の利用に重点を置いています。したがって、発展途上地域でのバイオテクノロジー産業の継続的な増加により、今後数年間で抗体発見市場に機会が生まれることが期待されます。
アジア太平洋の抗体発見市場の概要
アジア太平洋の抗体発見市場は、中国、日本、インド、韓国、オーストラリア、その他のアジア太平洋地域に分かれています。2022年には中国が最大の市場シェアを占め、インドは予測期間中に市場で大幅なCAGRを記録すると予想されています。中国のバイオ医薬品業界は大きな変化を遂げており、ジェネリック医薬品中心の環境から活気のあるイノベーションハブへと進化しています。さらに、工業化の進歩、新薬、ハイエンドの医療機器、技術の応用が、中国の抗体発見市場の成長に貢献しています。
中国では、心血管疾患やその他の慢性疾患の有病率が急増しています。Journal of Biomedical and Environmental Scienceによると、2021年には国内で約3億3000万人が心血管疾患を患っていました。抗体製品は、心血管疾患に対する新しい治療薬の開発に不可欠です。したがって、心臓病の蔓延が抗体発見の必要性を引き起こしています。研究センターの助けを借りて、抗体配列を研究し、新しい抗体を開発し、既存の抗体を最適化することができます。 Scimago Institute Rankingによると、2022年時点で中国には約170の医療研究センターがあり、日本（72）、オーストラリア（53）、インド（17）がそれに続きます。さらに、地理的拡大やその他の成長戦略のためにアジア太平洋諸国に焦点を当てている市場プレーヤーの数の増加、研究センターの数の増加、政府資金の顕著な増加は、アジア太平洋地域の抗体発見市場の成長を促進しています。
アジア太平洋地域の抗体発見市場の収益と2030年までの予測（10億米ドル）
アジア太平洋地域の抗体発見市場のセグメンテーション
アジア太平洋地域の抗体発見市場は、抗体の種類、性質、サービス、エンドユーザー、および国に分類されています。
抗体の種類に基づいて、アジア太平洋地域の抗体発見市場は、モノクローナル抗体、ポリクローナル抗体、その他に分類されます。モノクローナル抗体セグメントは、2022年にアジア太平洋地域の抗体発見市場で最大のシェアを占めました。
性質の面では、アジア太平洋地域の抗体発見市場は、ヒトおよびヒト化、キメラ、およびマウスに分類されます。ヒトおよびヒト化セグメントは、2022年にアジア太平洋地域の抗体発見市場で最大のシェアを占めました。
サービス別に見ると、アジア太平洋地域の抗体発見市場は、ファージディスプレイ、ハイブリドーマ、トランスジェニック動物、単一細胞、および酵母ディスプレイに分かれています。ファージディスプレイセグメントは、2022年にアジア太平洋地域の抗体発見市場で最大のシェアを占めました。
エンドユーザーに基づいて、アジア太平洋地域の抗体発見市場は、製薬およびバイオテクノロジー企業、研究室、その他に分類されます。製薬およびバイオテクノロジー企業セグメントは、2022年にアジア太平洋地域の抗体発見市場で最大のシェアを占めました。
国別に見ると、アジア太平洋地域の抗体発見市場は、中国、日本、インド、韓国、オーストラリア、その他のアジア太平洋地域に分類されます。2022年には、中国がアジア太平洋地域の抗体発見市場シェアを独占しました。
Charles River Laboratories International Inc、BioDuro LLC、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp、Biocytogen Pharmaceuticals Beijing Co Ltd.は、アジア太平洋地域の抗体発見市場で事業を展開している大手企業の一部です。
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Antibody Discovery Market – Key Market Dynamics
4.1 Asia Pacific Antibody Discovery Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Investments in Research & Development
4.2.2 Rising Incidence of Cancer
4.3 Market Restraints
4.3.1 High Cost of Production
4.4 Market Opportunities
4.4.1 Proliferation of Biotechnology Industry in Developing Regions
4.5 Future Trends
4.5.1 Developments for Custom Antibodies
4.6 Impact of Drivers and Restraints:
5. Antibody Discovery Market – Asia Pacific Market Analysis
5.1 Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020–2030
6. Asia Pacific Antibody Discovery Market Analysis – by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Antibody Discovery Market Analysis – by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Antibody Discovery Market Analysis – by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Antibody Discovery Market Analysis – by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Antibody Discovery Market – Country Analysis
10.1 Asia Pacific Antibody Discovery Market, Revenue and Forecast to 2030
10.1.1 Asia Pacific: Antibody Discovery Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China
10.1.1.1.1 Overview
10.1.1.1.2 China: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 China: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 China: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 China: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Japan
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Japan: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Japan: Antibody Discovery Market Breakdown, by End User
10.1.1.3 India
10.1.1.3.1 Overview
10.1.1.3.2 India: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 India: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 India: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 India: Antibody Discovery Market Breakdown, by End User
10.1.1.4 Australia
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
10.1.1.4.5 Australia: Antibody Discovery Market Breakdown, by Services
10.1.1.4.6 Australia: Antibody Discovery Market Breakdown, by End User
10.1.1.5 South Korea
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
10.1.1.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
10.1.1.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
10.1.1.6 Rest of Asia Pacific
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.6.4 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Nature
10.1.1.6.5 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Services
10.1.1.6.6 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 BioDuro LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Aragen Life Sciences Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Twist Bioscience Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Biocytogen Pharmaceuticals Beijing Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 4. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 5. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 6. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 7. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 8. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 9. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 10. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 11. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 12. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 13. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 14. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 16. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 17. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 18. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 19. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 20. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 21. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 22. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 23. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 24. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 25. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 26. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. Asia Pacific Antibody Discovery Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020 – 2030
Figure 4. Asia Pacific Antibody Discovery Market Share (%) – by Antibody Type (2022 and 2030)
Figure 5. Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Antibody Discovery Market Share (%) – by Nature (2022 and 2030)
Figure 9. Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Antibody Discovery Market Share (%) – by Services (2022 and 2030)
Figure 13. Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Antibody Discovery Market Share (%) – by End User (2022 and 2030)
Figure 19. Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Antibody Discovery Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 25. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 26. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- BioDuro LLC
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.